Neuroendocrine neoplasms of the appendix, colon and rectum.


Journal

Pathologica
ISSN: 1591-951X
Titre abrégé: Pathologica
Pays: Italy
ID NLM: 0401123

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 21 11 2020
accepted: 23 11 2020
entrez: 9 3 2021
pubmed: 10 3 2021
medline: 29 10 2021
Statut: ppublish

Résumé

Neuroendocrine neoplasms of the appendix, colon and rectum are classified according to the most recent WHO classification as neuroendocrine tumors (NET), neuroendocrine carcinomas (NEC) and mixed neuroendocrine-non neuroendocrine neoplasms (MiNENs). NECs and MiNENs are aggressive neoplasms requiring multimodal treatment strategies. By contrast, NETs are, in most cases, indolent lesions occurring as incidental findings in the appendix or as polyps in the rectum. While most appendiceal and rectal NETs are considered relatively non-aggressive neoplasms, a few cases, may show a more aggressive clinical course. Unfortunately, clinical/pathological characteristics to select patients at high risk of recurrence/metastases are poorly consolidated. Diagnosis is generally easy and supported by the combination of morphology and immunohistochemistry. Differential diagnostic problems are for NECs/MiNENs with poorly differentiated adenocarcinomas, when immunohistochemical neuroendocrine markers are not obviously positive, whereas for NETs they are represented by the rare appendiceal tubular and clear cell variants (which may be confused with non-neuroendocrine cancers) and rectal L-cell tumors which may be chromogranin negative and prostatic marker positive.

Identifiants

pubmed: 33686307
doi: 10.32074/1591-951X-230
pmc: PMC8138694
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-27

Informations de copyright

Copyright © 2021 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.

Références

Endocr Relat Cancer. 2018 May;25(5):583-593
pubmed: 29592868
Am J Surg Pathol. 2013 Apr;37(4):606-12
pubmed: 23426123
Neuroendocrinology. 2019;109(2):179-186
pubmed: 31060039
Ann Surg. 2020 Mar;271(3):527-533
pubmed: 29995678
Surg Endosc. 2016 Oct;30(10):4239-48
pubmed: 26718357
J Gastrointest Oncol. 2019 Apr;10(2):300-306
pubmed: 31032098
Am J Surg Pathol. 2015 May;39(5):632-43
pubmed: 25724002
Ann Surg. 2019 Jul;270(1):165-171
pubmed: 29557879
Front Oncol. 2016 Jul 18;6:173
pubmed: 27486567
Pediatr Blood Cancer. 2018 Aug;65(8):e27069
pubmed: 29745005
Hum Pathol. 2019 May;87:83-94
pubmed: 30851333
J Am Coll Surg. 1994 Aug;179(2):231-48
pubmed: 8044398
Am J Clin Pathol. 2010 May;133(5):809-14
pubmed: 20395531
Ann Surg Oncol. 2013 Apr;20(4):1170-8
pubmed: 23212760
Am J Surg Pathol. 2012 Apr;36(4):601-11
pubmed: 22314183
Pathol Res Pract. 2019 Jul;215(7):152448
pubmed: 31133441
Hum Pathol. 2018 Jul;77:166-174
pubmed: 29634977
Am J Surg Pathol. 2013 Jul;37(7):1044-52
pubmed: 23648459

Auteurs

Marco Volante (M)

Department of Oncology, University of Turin, Orbassano, Turin, Italy.
Pathology Unit, AOU San Luigi Gonzaga, Orbassano, Turin, Italy.

Federica Grillo (F)

Anatomic Pathology, Department of Surgical Sciences and Integrated Diagnostics, University of Genova, Italy.
Ospedale Policlinico San Martino IRCCS, Genova, Italy.

Federica Massa (F)

Pathology Unit, AOU San Luigi Gonzaga, Orbassano, Turin, Italy.

Francesca Maletta (F)

Pathology Unit, "Città della Salute e della Scienza" Hospital, Turin, Italy.

Luca Mastracci (L)

Anatomic Pathology, Department of Surgical Sciences and Integrated Diagnostics, University of Genova, Italy.
Ospedale Policlinico San Martino IRCCS, Genova, Italy.

Michela Campora (M)

Anatomic Pathology, Department of Surgical Sciences and Integrated Diagnostics, University of Genova, Italy.

Jacopo Ferro (J)

Anatomic Pathology, Department of Surgical Sciences and Integrated Diagnostics, University of Genova, Italy.

Alessandro Vanoli (A)

Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.

Mauro Papotti (M)

Department of Oncology, University of Turin, Orbassano, Turin, Italy.
Pathology Unit, "Città della Salute e della Scienza" Hospital, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH